Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
August 5, 2026
Medical Diagnostics & Screening
-
-
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung
July 27, 2026
-
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
July 22, 2026
-
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
July 6, 2026
-
Top National Health Plan Extends Agreement for Mental Health and Expands Dario Partnership into Cardiometabolic Care, Demonstrating Successful Multi-Condition Growth Strategy
July 2, 2026
-
Dario Announces Strategic Collaboration with Beluga Health to Deliver Provider-Backed, Integrated Care at Scale
June 29, 2026
-
Star Equity Holdings Added to the Russell Microcap® Index
June 29, 2026
-
VolitionRx Announces Collaboration with Sysmex
June 17, 2026
-
Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 8, 2026
-
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
June 1, 2026
-
BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development
May 29, 2026
-
KBS Builders Awarded $4.2 Million Contract for New Hampshire Multifamily Construction Project
April 30, 2026
-
bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment
April 28, 2026
-
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
April 20, 2026
-
Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System
March 12, 2026
-
Prenetics Authorizes $40 Million Share Repurchase Program
March 6, 2026